LFCR
Lifecore Biomedical·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 1
Consensus Rating "Strong Buy"
Ample Liquidity
Significant Net Income Decline
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About LFCR
Lifecore Biomedical, Inc.
A leading innovator of diversified health and wellness solutions
Life Science Tools and Services
10/31/1986
02/15/1996
NASDAQ Stock Exchange
406
12-31
Common stock
3515 Lyman Boulevard
Chaska
Minnesota 55318
--
Lifecore Biomedical, Inc., was incorporated in California on October 31, 1986 and re-registered as a Delaware corporation on November 6, 2008. The company and its subsidiaries design, develop, manufacture and sell differentiated products for the food and biomaterials markets and license technology applications to partners.
Earnings Call
Q4/2025
Estimate EPS-0.16
Actual EPS-0.06
Estimate Revenue35.31M
Actual Revenue36.44M
Lifecore Biomedical's Q4 2025: Unpacking Key Contradictions on Tariffs, Demand, and Market Growth
Aug 08,2025 09:28
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
LFCR has released its 2026 Q1 earnings. EPS was reported at -0.29, versus the expected -0.24, missing expectations. The chart below visualizes how LFCR has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
LFCR has released its 2025 Q4 earnings report, with revenue of 36.44M, reflecting a YoY change of -3.81%, and net profit of -1.15M, showing a YoY change of 83.81%. The Sankey diagram below clearly presents LFCR's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
